Industry News: The ongoing COVID-19 outbreaks underscore the importance of SARS-CoV-2 variant detection and tracking

15 Sep 2021


As the SARS-CoV-2 virus continues to spread and evolve, notably SARS-CoV-2 variants such as Delta, Delta Plus, Alpha that increase the transmissibility and decrease the effectiveness of diagnostics, vaccines and therapeutics have caused surges in global COVID-19 cases. 

To strengthen actions in epidemical control regarding the SARS-CoV-2 variants, WHO has classified them into 'Variants of Concern (VOC)' or 'Variants of Interest (VOI)' with a series of actions and measures. 

Under such circumstances, a leading IVD raw materials and one-stop solution organization, Fapon Biotech, introduced the GRASPlex SARS-CoV-2 Full Length Genome Panel for SARS-CoV-2 known and emerging variant detection, virus source identification, mutation monitoring, study virus evolution, and others. 

Product features & benefits

  • 99% coverage of the SARS-CoV-2 viral genome 
  • Enrichment & library sequencing in one tube, two-step
  • Uniformity and on-target rate over 95%
  • Various forms of cooperation to provide different modules & bioinformatic analysis service
  • Reduction in pre-sequencing cost

Product performance

1. The sequencing output is more than 2M reads with Mapping Rate >99%, Ontarget Rate >95% and Uniformity Rate >95%

The sequencing output is more than 2M reads with Mapping Rate >99%, Ontarget Rate >95% and Uniformity Rate >95%

2. High uniformity with low copy number inputs 

High uniformity with low copy number inputs

3. Excellent detection correlation between sample templates of different copy numbers

Excellent detection correlation between sample templates of different copy numbers

4. High-depth coverage of SARS-CoV-2 variant key mutation sites

High-depth coverage of SARS-CoV-2 variant key mutation sites

For more information, download the product brochure>>